In postmenopausal women, estrogen deficiency plays a critical role in bone resorption, exacerbating the risk of osteoporosis, particularly among individuals with diabetes, who may experience further dysregulation of bone remodeling markers such as parathyroid hormone (PTH) and alkaline phosphatase (ALP) [10]. Here, PTH is linked to diabetes mellitus.